Sort
23,748 grants matching “melanoma”
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$581,057Kathryn Miller-Jensen · Yale University · U01 · FY2020 · CA
Multi-level Assessment of Indoor Tanning Practices
$581,038San Diego State University · R01 · FY2004 · CA
VLA-4âtargeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
$580,985Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
TNF-receptors and programmed cell death in regulation of autoimmunity
$580,944Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer
$580,865John N Weinstein · Basic Sciences · Z01 · FY2007 · CA
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
$580,820Anna Karolina Palucka · Baylor Research Institute · R01 · FY2011 · CA
Development of an autologous humanized model of melanoma exploring human thymic education capacity
$580,793Antonio Jimeno · University Of Colorado Denver · R01 · FY2017 · CA
Development of an autologous humanized model of melanoma exploring human thymic education capacity
$580,793Antonio Jimeno · University Of Colorado Denver · R01 · FY2019 · CA
Development of an autologous humanized model of melanoma exploring human thymic education capacity
$580,793Antonio Jimeno · University Of Colorado Denver · R01 · FY2018 · CA
A personalized approach to skin cancer prevention among adolescents
$580,551Yelena Ping Wu · University Of Utah · R01 · FY2022 · CA
Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging
$580,392Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$580,336Joseph C Wu · Stanford University · R01 · FY2020 · HL
TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction
$580,177Mary Philip · Vanderbilt University Medical Center · R37 · FY2022 · CA
Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism
$580,136Arlene H Sharpe · Harvard Medical School · R01 · FY2023 · CA
Cell type-directed Tim-3 targeting in melanoma
$580,109Steven Russell Barthel · Brigham And Women'S Hospital · R01 · FY2025 · CA
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
$580,072Kevan C Herold · Yale University · R01 · FY2021 · CA
SWOG Community Clinical Oncology Program Research Base
$579,978Charles D. Blanke · Oregon Health & Science University · U10 · FY2014 · CA
Family Studies
$579,889Margaret Tucker · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
$579,607Venkatram Reddy Atigadda · University Of Alabama At Birmingham · R01 · FY2024 · CA
Reducing Errors in the Diagnosis of Melanoma and Melanocytic Lesions
$579,575Joann G Elmore · University Of California Los Angeles · R01 · FY2019 · CA
G alpha-q/11 Signaling and Inhibition in Ocular Melanoma
$579,510Kendall Jay Blumer · Washington University · R01 · FY2021 · CA
Enhanced Development of the Xiphophorus Model System
$579,475Ronald Walter · Texas State University · R24 · FY2018 · OD
Enhanced Development of the Xiphophorus Model System
$579,475Ronald Walter · Texas State University · R24 · FY2016 · OD
Purchase of a PerkinElmer IVIS SpectrumCT Imaging System
$579,346Paul M. Lieberman · Wistar Institute · S10 · FY2017 · OD
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
$578,977Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R44 · FY2024 · CA